XENE compared with CRNX: revenue, margins and what each company keeps, and the suppliers and customers both name

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

CRNXCrinetics Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

XENEXenon Pharmaceuticals Inc.

CRNXCrinetics Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

XENE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.1%▼−1.84%×0.20

May 8 '26±10.3%▲+0.79%×0.08

Q1 FY26±30.3%▼−3.76%×0.13

Nov 4 '25±8.7%▼−4.94%×0.56

CRNX

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±1.1%▲+0.12%×0.09

May 8 '26±9.5%▼−13.82%×1.45

= impliedXENE realized, solidCRNX realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.4%

▼−6.04%

×0.48

Jan 6 '26±10.1%▼−4.63%×0.46

XENEXenon Pharmaceuticals Inc.

39.15▲+3.90%· post 39.07

Mkt cap$3.8BRevenue$8MQ1 FY25Revenue—

CRNXCrinetics Pharmaceuticals, Inc.

84.97▲+0.15%· post 84.97

ClosedNov 6 '26

Mkt cap$509.7MRevenue$25MQ2 FY26Revenue$8MFY25

Compare

ClosedNov 6 '26

XENEXenon Pharmaceuticals Inc.

CRNXCrinetics Pharmaceuticals, Inc.

39.15▲+3.90%post 39.07

Price

84.97▲+0.15%post 84.97

$3.8B

Mkt cap

$509.7M

Q1 FY25$8M

Revenue

$25MQ2 FY26

—

Revenue

$8MFY25

XENE39.15▲+3.90%vsCRNX84.97▲+0.15%ClosedNov 6 '26